LASEROPTEK Co., Ltd., a developer, and manufacturer of world-class lasers for aesthetic and medical dermatology, proudly announces its strategic partnership with The Pinnacle Health Group.
BizLink, a leading global interconnect solutions provider, announced the introduction of a new range of robotic arms today – the BizLink PULSAR platform. Being ultrasafe and precise it is ideal to use for medical and para-medical applications.
Xenter, Inc. announced the recent unveiling of its groundbreaking dual sensor investigational guidewire for TAVR procedures at the Transcatheter Cardiovascular Therapeutics.
Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, announced that the Centers for Medicare and Medicaid Services (CMS) assigned payment for a new Category I Current Procedural Terminology.
Toku, Inc., a commercial medical device company specializing in imaging technology and AI, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to its patented CLAiR technology.
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced new findings from the Q-FFICIENCY study were published in the Journal of Cardiovascular Electrophysiology demonstrating treatment with the QDOT MICRO™ Catheter significantly improved control of atrial fibrillation (AFib), relief of symptoms and overall quality of life.
QuantalX Neuroscience, a pioneering healthcare company dedicated to early detection of brain disorders, is pleased to announce that it has secured a US reimbursement code, 0858T, from the American Medical Association (AMA). This milestone achievement is a significant part of the company's pre-commercialization strategy in the US.
EyeCheq, a leading innovator in eye care technology with its fully autonomous eye screening platform, is pleased to announce the expansion of their Leadership Team. Dr. Ruwan Silva will serve as Chief Medical Officer and Christopher Grant as EVP of Operations to strengthen EyeCheq's scientific and operational expertise.
Genezen, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO),announced the closing of an $18.5 million follow-on growth equity investment led by Ampersand Capital Partners.
Xēnix Medical, a surgical implant company focused on the development of novel science-based solutions for patients requiring spinal fusion surgery, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the SOLACE™️ Sacroiliac Fixation System with proprietary NANOACTIV™️ surface technology and compatibility with StealthStation® Navigation.